RNA N6-methyladenosine (m6A) deposition by the METTL3–METTL14 complex regulates RNA metabolism and thereby influences cell differentiation and stress responses. Dysregulated m6A deposition has been implicated in multiple cancers, where METTL3–METTL14 supports oncogenic programs. Yet the molecular basis of RNA recogniti...
Francesco Fiorentino, Bo-Yi Xiao, Bianca Cesaro et al.· Journal of the American Chem...· 0 citations
Epigenetic modulators and immune checkpoint inhibitors represent two major therapeutic avenues in oncology, yet resistance and recurrence limit their efficacy. To address this, we designed and synthesized a series of dual histone deacetylase (HDAC)/PD-1/PD-L1 inhibitors (compounds 1−6). Among them, compounds 4 (HDAC6...
Alessia Raucci, A. Fragale, I. Pacella et al.· Journal of Medicinal Chemist...· 0 citations
INTRODUCTION
Sirtuins (SIRT1-7) are NAD+-dependent lysine deacylase and mono-ADP ribosyl transferase enzymes that integrate metabolic status with epigenetic regulation, genome maintenance, mitochondrial homeostasis, and adaptive stress responses. Their dysregulation is implicated in cancer, neurodegeneration, cardiomet...
Emanuele Fabbrizi, G. Hailu, Andrea Mancini et al.· Expert opinion on therapeuti...· 0 citations
Targeted protein degradation (TPD) has transformed drug discovery by enabling event-driven elimination of pathogenic proteins, but many diseases arise from protein insufficiency and require restoration rather than removal. Deubiquitinase (DUB)-targeting chimeras (DUBTACs) offer a complementary proximity-pharmacology ap...
G. Hailu, Emanuele Fabbrizi, Andrea Mancini et al.· Drug Discovery Today· 0 citations
Advances provide the first chemical foothold for therapeutic modulation of m7G pathways and underscore METTL1 as a promising yet complex target requiring careful biological stratification.
Emanuele Fabbrizi, Gebremedhin S. Hailu, Andrea Mancini et al.· Journal of Medicinal Chemist...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.